Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...

The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Vertex Pharmaceuticals trades at $500.94 and has moved in lockstep with the market. Its shares have returned 5.5% over the ...

The Nasdaq Composite Index ( ^IXIC -4.00%) is now squarely in correction territory. But stock market corrections have one key ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Well thanks very much, everyone, for joining us for our next session with Vertex. My name is Dave Risinger ... or digital sales effort we have kind of non-personal outreach to other aspects ...

Vertex Pharma could be close to succeeding in ... arm safety and effectiveness study of the drug in various surgical and non-surgical pain settings. Treatment with the drug was associated with ...

The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.

Credit to its robust bankability, supreme technological capability, and the worldly renowned 210mm n-type TOPCon modules ...

Tariff worries pushed the ASX down, coal took a hit after Macquarie's call, while gold climbed as the market edged closer to ...